You say in a later post you used Stockman's numbers, I think you used mine.
(Stockman's) 23.6M OS + 6.3M = 29.9M OS.
(GunnerG) 23.6M OS + 12.6 = 36.2M OS
sah1 wrote:The value of the Ryplazim platform and voucher remains the same. So $600M divided by 36M (assuming warrants exercised) equates to about $16. This gives zero value to the small molecule division which is consistent with current market pricing.